While Dr Imran Patel’s intentions appeared pure, viewers felt he went a little too far in trying to pacify a toddler during ...

FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...

Now imagine swapping some of that hardware for medicated skin cream that never pokes your skin. That is the vision behind a new Nature study describing a polymer that can haul insulin straight through ...

The Injector Collective is a revolutionary platform designed specifically for licensed injectors and medspa professionals. It ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

The approvals come as a pleasant surprise for Regeneron, analysts say, helping bolster the overall product profile of ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing option in all approved indications provides greater dosing ...

Regeneron has won two US Food and Drug Administration (FDA) approvals for Eylea HD (aflibercept), adding another indication ...

A groundbreaking polymer-based skin cream shows promise in replacing painful daily insulin injections for diabetes management ...

III-directed small interfering ribonucleic acid designed to reduce levels of hepatic and serum apoC-III protein, thereby increasing clearance of serum TGs.

Embecta's Q4 earnings loom as product momentum, global trends and recent strategic gains set the stage for potential top-line ...

Orforglipron, a GLP-1 drug taken as a pill, achieved positive results in people with obesity and type 2 diabetes, although it ...